HARVARD BIOSCIENCE INC (HBIO) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001123494 · SEC filings checked Oct 17, 2026

    Next report
    Nov 10, 2026
    Estimated from reporting history (91-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $8.09
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $9.25
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 0.9

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 11, 2026$22.7M$-2.9M$-0.64Filing
    Mar 31, 2026May 12, 2026$20.8M$-3.4M$-0.77Filing
    Dec 31, 2025Feb 10, 2026$23.7M$-2.8M$10.69Filing
    Sep 30, 2025Nov 6, 2025$20.6M$-1.2M$-0.03Filing
    Jun 30, 2025Aug 11, 2025$20.4M$-2.3M$-0.52Filing
    Mar 31, 2025May 12, 2025$21.8M$-50.3M$-11.42Filing
    Dec 31, 2024Mar 12, 2025$24.6M$18,000$0.01Filing
    Sep 30, 2024Nov 7, 2024$22.0M$-4.8M$-0.11Filing

    What would HARVARD BIOSCIENCE INC have to report for its valuation to change?

    At $8.09, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -40.5% a year, to $0.69. On that path the next quarter needs diluted EPS near $-0.02, against $-0.03 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year-40.5%-40.5%
    EPS needed in final year$0.69$0.69

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. HBIO goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.